(Q34137148)

31 July 2017

Virologic and immunologic response to HAART, by age and regimen class (English)

1 reference

31 July 2017

0 references

Stephen J Gange

3

0 references

Michael John Gill

object named as

M John Gill

7

0 references

Steven G Deeks

4

object named as

Steven G Deeks

1 reference

31 July 2017

9

Sonia Napravnik

1 reference

31 July 2017

5

Michael S Saag

1 reference

31 July 2017

2

Amy C Justice

1 reference

31 July 2017

1

Keri N Althoff

1 reference

31 July 2017

12

Kelly A Gebo

1 reference

31 July 2017

6

Michael J Silverberg

1 reference

31 July 2017

Bryan Lau

8

1 reference

31 July 2017

Ellen Tedaldi

10

1 reference

31 July 2017

Marina B Klein

11

1 reference

31 July 2017

North American AIDS Cohorts Collaboration on Research, Design (NA-ACCORD)

13

1 reference

31 July 2017

language of work or name

English

0 references

publication date

1 October 2010

1 reference

31 July 2017

1 reference

31 July 2017

24

1 reference

31 July 2017

2469-2479

1 reference

31 July 2017

16

1 reference

Effect of age and HAART regimen on clinical response in an urban cohort of HIV-infected individuals

31 July 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3136814

Class-sparing regimens for initial treatment of HIV-1 infection

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3136814

Immunologic and clinical responses to highly active antiretroviral therapy in patients with HIV infection aged >50 years.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3136814

Cohort profile: the North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD).

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3136814

Comparison of dynamic treatment regimes via inverse probability weighting

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3136814

Older age does not influence CD4 cell recovery in HIV-1 infected patients receiving highly active antiretroviral therapy

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3136814

Medication adherence in HIV-infected adults: effect of patient age, cognitive status, and substance abuse

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3136814

Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3136814

The incubation period of AIDS.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3136814

Antiretroviral treatment of adult HIV infection: 2008 recommendations of the International AIDS Society-USA panel

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3136814

Response to combination antiretroviral therapy: variation by age.

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3136814

HIV infection in older adults

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3136814

Older age and the response to and tolerability of antiretroviral therapy

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3136814

Older age and plasma viral load in HIV-1 infection.

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3136814

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3136814

Clinical experience with human immunodeficiency virus-infected older patients in the era of effective antiretroviral therapy

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3136814

Influence of age on CD4 cell recovery in human immunodeficiency virus-infected patients receiving highly active antiretroviral therapy: evidence from the EuroSIDA study

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3136814

Influence of age at infection on human immunodeficiency virus disease progression to different clinical endpoints: the SEROCO cohort (1988-1994). The Seroco Study Group

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3136814

A case-control study of virological and immunological effects of highly active antiretroviral therapy in HIV-infected patients with advanced age

28 October 2018

1 reference

12 December 2020

Immunologic and virologic response to highly active antiretroviral therapy in the Multicenter AIDS Cohort Study

1 reference

12 December 2020

Response to highly active antiretroviral therapy in HIV-infected patients aged 60 years or older after 24 months follow-up

1 reference

12 December 2020

Older HIV-positive patients in the era of highly active antiretroviral therapy: changing of a scenario

1 reference

12 December 2020

Antiretroviral treatment and advanced age: epidemiologic, laboratory, and clinical features in the elderly

1 reference

12 December 2020

Adjusted survival curves with inverse probability weights

1 reference

12 December 2020

Adjusting for non-compliance and contamination in randomized clinical trials

1 reference

12 December 2020

Immunologic and clinical responses to highly active antiretroviral therapy over 50 years of age. Results from the French Hospital Database on HIV

1 reference

12 December 2020

A comparison of three highly active antiretroviral treatment strategies consisting of non-nucleoside reverse transcriptase inhibitors, protease inhibitors, or both in the presence of nucleoside reverse transcriptase inhibitors as initial therapy (CP

1 reference

12 December 2020

Effects of age and sex on immunological and virological responses to initial highly active antiretroviral therapy

1 reference

12 December 2020

Inverse probability-of-censoring weights for the correction of time-varying noncompliance in the effect of randomized highly active antiretroviral therapy on incident AIDS or death

1 reference

12 December 2020

10.1097/QAD.0B013E32833E6D14

Identifiers

DOI

1 reference

31 July 2017

1 reference

31 July 2017

1 reference